Another Blow To Aduhelm As Biogen Withdraws EU Filing

Adds To US Commercial Failure

Biogen
Biogen has withdrawn its filing with the EMA but has indicated it could resubmit if the evidence base changes. • Source: Alamy

More from Business

More from Scrip